2013
Mortality as an adverse outcome of sarcopenia
Abstract: Sarcopenia has an important impact in elderly. Recently the European Working Group on Sarcopenia in Older People (EWGSOP) defined sarcopenia as the loss of muscle mass plus low muscle strength or low physical performance. Lack of clinical sounding outcomes (ie external validity), is one of the flaws of this algorithm. The aim of our study was to determine the association of sarcopenia and mortality in a group of Mexican elderly. A total of 345 elderly were recruited in Mexico City, and followed up for three ye…
Search citation statements
Paper Sections
Select...
161
71
43
5
Citation Types
4
164
2
7
Year Published
2013
2026
Publication Types
Select...
227
29
8
6
Relationship
0
270
Authors
Journals
Cited by 256 publications
(177 citation statements)
References 24 publications
4
164
2
7
“…We compared the latest criteria of the AWGS2019 with other diagnostic criteria in this study, and found that the incidence of sarcopenia under different criteria varied from 2.3 to 12.2%, with the highest prevalence diagnosed by EWGSOP1 criteria and the lowest prevalence diagnosed by FNIH. Our results is accordance with the prevalence of sarcopenia reported by current studies (8–50%) [ 15 ]. One of the main reasons may be that the diagnostic criteria for sarcopenia are inconsistent.…”
Section: Discussionsupporting
confidence: 94%
“…We compared the latest criteria of the AWGS2019 with other diagnostic criteria in this study, and found that the incidence of sarcopenia under different criteria varied from 2.3 to 12.2%, with the highest prevalence diagnosed by EWGSOP1 criteria and the lowest prevalence diagnosed by FNIH. Our results is accordance with the prevalence of sarcopenia reported by current studies (8–50%) [ 15 ]. One of the main reasons may be that the diagnostic criteria for sarcopenia are inconsistent.…”
Section: Discussionsupporting
confidence: 94%
“…Our results support and extend findings by Arango-Lopera et al , 23 who reported a prevalence of sarcopaenia of 33.6% in 345 community-living older adults (mean age 78.5 years; 53.3% females) and an adjusted mortality HR of 2.39 over a 3-year follow-up. As in the present study, the identification of sarcopaenia was based on the EWGSOP criteria, using anthropometry for estimating muscle mass.…”
Section: Discussionsupporting
confidence: 92%
“…We adjusted for potential confounders that included demographic, behavioural, and clinical characteristics, and sarcopenia remained a significant predictor of all‐cause mortality. This finding is consistent with prior reports documenting the deleterious effect of sarcopenia on all‐cause mortality . Sarcopenia was also a significant risk factor for cardiovascular‐specific mortality for females, but not males.…”
Section: Discussionsupporting
confidence: 92%
